Labcorp’s Q4 results came in below Wall Street’s revenue expectations, leading to a negative market reaction, while ...

Labcorp (NYSE:LH) executives said the company delivered what CEO Adam Schechter called a “very strong year” in 2025, citing ...

Labcorp’s pathologists will use the software to review, interpret and manage digital images of slides for primary diagnosis.

Adam H. Schechter, President and CEO of Labcorp Holdings Inc. (NYSE:LH), a $20.4 billion healthcare services provider currently trading near its 52-week high of $258.59, sold 6,121 shares of the ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities within the organization in connection with our LaunchPad initiatives ...

Good day, and thank you for standing by. Welcome to Labcorp's Fourth Quarter 2024 Conference Call [Operator Instructions]. Please be advised today's conference being recorded. I would now like to hand ...

Labcorp CEO Adam Schechter on Tuesday urged Americans to be vaccinated against Covid-19 and told CNBC that recipients are not being advised to be tested for Covid antibodies afterward. "At the moment, ...

Feb 17 (Reuters) - Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, ...

Thursday, Laboratory Corp (NYSE: LH) reported fourth-quarter 2024 adjusted earnings per share of $3.45, up from $3.30 a year ago, beating the consensus of $3.39. Sales increased 9.8% year-over-year to ...

"In 2025, Labcorp grew revenue over 7% and delivered double-digit adjusted EPS growth, margin expansion and strong free cash flow. Performance was driven by continued strength in our Diagnostics and ...

Labcorp took a series of steps to expand in New York last year. In October, the company disclosed deals to buy assets from Empire City and Laboratory Alliance of Central New York, a pathology ...